Literature DB >> 9514306

Increased circulating products of lipid peroxidation in patients with alcoholic liver disease.

S I Aleynik1, M A Leo, M K Aleynik, C S Lieber.   

Abstract

F2-isoprostanes (F2-IP) and 4-hydroxynonenal (4-HNE), peroxidation products of polyunsaturated fatty acids (PUFA), are considered the most reliable indicators of endogenous lipid peroxidation in vivo. To determine to what extent these are also altered in patients with alcoholic liver disease, plasma free and esterified F2-IP as well as 4-HNE were measured by GC/MS in 49 fasting subjects who underwent diagnostic percutaneous needle biopsies of the liver. Compared to patients with mild steatosis and no fibrosis, free F2-IP and 4-HNE were strikingly increased in individuals with alcoholic hepatitis. There was also a significant but lesser rise of 4-HNE in patients with perivenular fibrosis. An increase of F2-IP was also found in subjects with transition to, or complete, alcoholic cirrhosis, with a comparable trend for 4-HNE. By contrast, in patients who were drinking heavily up to 48 hr before admission, F2-IP were not abnormal, but they increased later (p < 0.005). Contrasting with plasma free F2-IP, esterified F2-IP were not significantly changed with fibrosis. Thus, whereas circulating esterified F2-IP were unchanged in patients with alcoholic liver disease, there was an increase in free F2-IP as well as 4-HNE during recovery from intoxication. The increase was not a result of accompanying hepatitis C but a function of the stage of alcoholic liver injury, possibly reflecting enhanced lipid peroxidation as well as interference with biliary excretion and/or hepatic esterification.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514306

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  22 in total

1.  Characterization of the effects of isoprostanes on platelet aggregation in human whole blood.

Authors:  J H Cranshaw; T W Evans; J A Mitchell
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Peripubertal paternal EtOH exposure.

Authors:  N V Emanuele; N LaPagli; J Steiner; A Colantoni; D H Van Thiel; M A Emanuele
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

3.  Increased hepatocellular protein carbonylation in human end-stage alcoholic cirrhosis.

Authors:  C T Shearn; D J Orlicky; L M Saba; A H Shearn; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2015-10-27       Impact factor: 7.376

Review 4.  Role of alcohol in the development and progression of hepatocellular carcinoma.

Authors:  Iain H McKillop; Laura W Schrum; Kyle J Thompson
Journal:  Hepat Oncol       Date:  2015-11-30

Review 5.  Targeting Nrf-2 is a promising intervention approach for the prevention of ethanol-induced liver disease.

Authors:  Ning Zhao; Fang-Fang Guo; Ke-Qin Xie; Tao Zeng
Journal:  Cell Mol Life Sci       Date:  2018-06-11       Impact factor: 9.261

6.  Alcohol-induced generation of lipid peroxidation products in humans.

Authors:  E A Meagher; O P Barry; A Burke; M R Lucey; J A Lawson; J Rokach; G A FitzGerald
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

7.  Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis.

Authors:  Lorraine B Ware; Joshua P Fessel; Addison K May; L Jackson Roberts
Journal:  Shock       Date:  2011-07       Impact factor: 3.454

Review 8.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

9.  Eat more carrots? Dampening cell death in ethanol-induced liver fibrosis by β-carotene.

Authors:  Linda Hammerich; Frank Tacke
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

10.  The Combination of S-adenosylmethionine and Dilinoleoylphosphatidylcholine Attenuates Non-alcoholic Steatohepatitis Produced in Rats by a High-Fat Diet.

Authors:  Charles S Lieber; Maria A Leo; Qi Cao; Ki M Mak; Chaoling Ren; Anatoly Ponomarenko; Xiaolei Wang; Leonore M Decarli
Journal:  Nutr Res       Date:  2007-09       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.